INS and diabetes mellitus: As patients with PTDM share common metabolic CVD risk factors with those with pre-transplant diabetes, the mechanistic pathways of abnormalities in insulin sensitivity and insulin secretion resulting in adverse CVD outcomes are likely to be similar (107–111).